SGN-15

· Seagen Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SGN-15, covering 2011-10-24 to 2011-10-24. Get the full timeline:

Most recent: Clinical Trial Update: FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma [Phase 2]